Characterization of recombinant antibodies developed for capturing enterohemorrhagic Escherichia coli O157:H7

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 35, Issue 4, 2004, Pages 902-912

  Kanitpun, Reka ^a,b   Wagner, G Gale ^a   Waghela, Suryakant D ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN; POLYCLONAL ANTIBODY; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; CLONE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLAGELLUM; GASTROINTESTINAL HEMORRHAGE; HYBRIDOMA; MOLECULAR CLONING; PHAGE DISPLAY;

EID: 12444272037     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. rd. Recent advances in phage display. Curr Opin Biotechnol 1993; 4: 526-30.
2. Barbet AF, Anderson LW, Palmer GH, McGuire TC. Comparison of protein synthesized by two different isolates of Anaplasma marginale. Infect Immun 1983; 40: 1068-74.
3. Burioni R, Plaisant P, Bugli F, Delli Carri V, Clementi M, Fadda G. A vector for the expression of recombinant monoclonal Fab fragments in bacteria. J Immunol Methods 1988; 217: 195-9.
4. Burton DR. Phage display. Immunotechnology (Amsterdam) 1995; 1: 87-94.
5. Casalvilla R, Duenas M, Ayala M, et al. A bacterial single-chain Fv antibody fragment that inhibits binding of its parental anti-E-selectin monoclonal antibody to activated human endothelial cells. J Biotechnol 1999; 72: 1-12.
6. Chapman PA, Siddons CA. A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli 0157 from cases of bloody diarrhoea, non-bloody diarrhoea and asymptomatic contacts. J Med Microbiol 1996; 44: 267-71.
7. Chapman PA, Malo AT, Siddons CA, Harkin M. Use of commercial enzyme immunoassays and immunomagnetic separation systems for detecting Escherichia coli O157 in bovine fecal samples. Appl Environ Microbiol 1997; 63: 2549-53.
8. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate phenolchoroform extraction. Anal Biochem 1987; 162: 2957-63.
9. Choi KS, Nah JJ, Choi CU, et al. Monoclonal antibody-based competitive ELISA for simultaneous detection of rinderpest virus and peste des petits ruminant virus antibodies. Vet Microbiol 2003; 96: 1-16.
10. Feld NC, Qvist P, Ahrens P, Friis NF, Meyling A. A monoclonal blocking ELISA detecting serum antibodies to Mycoplasma hyopneumoniae. Vet Microbiol 1992; 30: 35-46.
11. Fukushima H, Hoshina K, Gomyoda M. Selective isolation of eae-positive strains of shiga toxin-producing Escherichia coli. J Clin Microbiol 2002; 38: 1684-7.
12. Gavilondo JV, Larrick JW. Antibody engineering at the millennium. BioTechniques 2000; 29: 128-49.
13. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991; 13: 60-98.
14. nd ed. Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. New York, NY: Lippincott Williams & Wilkins, 2002: 627-42.
15. Horton RM. PCR-mediated recombination and mutagenesis. SOEing together tailor-made genes. Mol Biotechnol 1995; 3: 93-9.
16. Huse WD, Sastry L, Iverson SA, et al. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science 1989; 246: 1275-81.
17. Kim MS, Doyle MP. Dipstick immunoassay to detect enterohemorrhagic Escherichia coli O157:H7 in retail ground beef. Appl Environ Microbiol 1992; 58: 1764-7.
18. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-7.
19. Marx U, Embleton MJ, Fischer R, et al. Monoclonal antibody production. The report and recommendations of ECVAM Workshop 23. ATLA 1997; 25: 121.137.
20. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990; 348: 552-4.
21. Mori Y, Hamaoka T, Sato S. Use of monoclonal antibody in an enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against Mycoplasma hyopneumoniae. Israel J Med Sci 1987; 23: 657-62.
22. Nagesha HS, Wang LF, Shiell B, Beddome G, White JR, Irving RA. A single chain Fv antibody displayed on phage surface recognizes conformational group-specific epitope of bluetongue virus. J Virol Methods 2001; 91: 203-7.
23. Nataro JP, Kaper JP. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11: 142-201.
24. O' Brien AD, La Veck GD. Purification and characterization ofaShigella dysenteriae 1-like toxin produced by Escherichia coli. Infect Immun 1983; 40: 675-83.
25. Paton AW, Paton JC. Direct detection and characterization of Shiga toxigenic Escherichia coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa. J Clin Microbiol 2002; 40: 271-4.
26. Pearson TW, Pinder M, Roelants GE, et al. Methods for derivation and detection of anti-parasite monoclonal antibodies. J Immunol Methods 1980; 34: 141-54.
27. Plückthun A, Skerra A. Expression of functional antibody Fv and Fab fragments in Escherichia coli. Meths Enzymol 1989; 178: 497-515.
28. Pyle BH, Broadway SC, McFeters GA. Sensitive detection of Escherichia coli O157:H7 in food and water by immunomagnetic separation and solid-phase laser cytometry. Appl Enivron Microbiol 1999; 65: 1966-72.
29. Riley LW. The epidemiologic, clinical, and microbiological features of hemorrhagic colitis. Annu Rev Microbiol 1987; 41: 383-407.
30. Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983; 308: 681-5.
31. Shelton DR, Van Kessel JS, Wachtel MR, Belt KT, Karns JS. Evaluation of parameters affecting quantitative detection of Escherichia coli O157 in enriched water samples using immunomagnetic electrochemiluminescence. J Microbiol Meths 2003; 55: 717-25.
32. ShengFeng C, Suen LP, Xin TW, Feng WG. Construction, expression, purification, refold and activity assay of a specific ScFv fragment against foot and mouth disease virus. Vet Res Commun 2003; 27: 243-56.
33. Sherman P, Soni R, Yeger H. Characterization of flagella purified from enterohemorrhagic, vero cytotoxin-producing Escherichia coli serotype O157:H7. J Clin Microbiol 1988; 26: 1367-72.
34. Thomas A, Jiggle B, Smith HR, Rowe B. The detection of vero cytotoxin-producing Escherichia coli and Shigella dysenteriae type 1 in faecal specimens using polymerase chain reaction gene amplification. Lett Appl Microbiol 1994; 19: 406-9.
35. Towbin H, Gordon J. Immunoblotting and dot immunobinding: current status and outlook. J Immunol Meth 1984; 72: 313-40.
36. Waghela SD, Melendy D, Cruz D, Wagner G. Antigenic analysis of Anaplasma marginale grown in bovine erythrocytes co-cultured with bovine endothelial cells. Vet Parasitol 2000; 94: 133-9.
37. Westphal O, Jann K. Bacterial lipopolysaccharide: extraction with phenol-water and further applications of the procedure. Meth Carbohyd Chem 1965; 5: 83-91.
38. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR. Making antibodies by phage display technology. Annu Rev Immunol 1994; 12: 433-55.
39. Wright DJ, Chapman PA, Siddons CA. Immunomagnetic separation as a sensitive method for isolating Escherichia coli O157 from food sample. Epidemiol Infect 1994; 113: 31-9.
40. Zhou B, Wirsching P, Janda KD. Human antibodies against spores of the genus Bacillus: a model study for detection of and protection against anthrax and the bioterrorist threat. Proc Natl Acad Sci USA 2002; 99: 5241-6.